Amedeo Smart

Free Medical Literature Service


 

Amedeo

Genetics

  Free Subscription

Articles published in
Cancer
    March 2024
  1. KOTECHA RR, Knezevic A, Arora K, Bandlamudi C, et al
    Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
    Cancer. 2024;130:692-701.
    >> Share

    February 2024
  2. YEKU OO
    Racial disparities and referral for genetic counseling.
    Cancer. 2024;130:505-506.
    >> Share

    November 2023
  3. HOWARD SHARP KM, Nichols KE
    Insights into parent and adolescent patient understanding of genomic sequencing.
    Cancer. 2023;129:3519-3521.
    >> Share

    October 2023
  4. NIERENGARTEN MB
    Genomics likely are not the main driver in advanced prostate cancer overall survival rate disparities.
    Cancer. 2023;129:3192.
    >> Share

    September 2023
  5. DASH C, Mills MG, Jones TD, Nwabukwu IA, et al
    Design and pilot implementation of the Achieving Cancer Equity through Identification, Testing, and Screening (ACE-ITS) program in an urban underresourced population.
    Cancer. 2023;129.
    >> Share

    June 2023
  6. MOORADIAN MJ, Cleary JM, Giobbie-Hurder A, Darville LNF, et al
    Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors.
    Cancer. 2023;129:1904-1918.
    >> Share

    April 2023
  7. NIERENGARTEN MB
    Helping oncologists utilize genomics in cancer care: An updated definition of the uses of genetic biomarkers in cancer diagnosis and care can make a difference in how physicians understand their use in the clinic.: An updated definition of the uses of
    Cancer. 2023;129:1140-1141.
    >> Share

    March 2023
  8. OHYAMA H, Hirotsu Y, Amemiya K, Miura Y, et al
    Comparison of genomic profiling of circulating tumor DNA in pancreaticobiliary malignancies in plasma and bile.
    Cancer. 2023 Mar 18. doi: 10.1002/cncr.34717.
    >> Share

  9. WILLIAM WN JR, Zhang J, Zhao X, Parra ER, et al
    Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
    Cancer. 2023;129:714-727.
    >> Share

    February 2023
  10. GUPTA DG, Varma N, Kumar A, Naseem S, et al
    Genomic and proteomic characterization of Philadelphia-like B-lineage acute lymphoblastic leukemia: A report of Indian patients.
    Cancer. 2023 Feb 3. doi: 10.1002/cncr.34665.
    >> Share

    January 2023
  11. WIN TS, Tsao H
    Keratinocytic skin cancers-Update on the molecular biology.
    Cancer. 2023 Jan 16. doi: 10.1002/cncr.34635.
    >> Share

    December 2022
  12. FREY MK, Ahsan MD, Badiner N, Lin J, et al
    What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.
    Cancer. 2022;128:4241-4250.
    >> Share

    May 2022
  13. LOKE J, Labopin M, Craddock C, Cornelissen JJ, et al
    Additional cytogenetic features determines outcome in patients allografted for TP53 mutant acute myeloid leukemia.
    Cancer. 2022 May 25. doi: 10.1002/cncr.34268.
    >> Share

    April 2022
  14. REIZINE NM, Danahey K, Truong TM, George D, et al
    Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
    Cancer. 2022;128:1649-1657.
    >> Share

  15. STADLER WM, Hlubocky FJ, Hathaway F
    Knowledge and distress in complex cancer care.
    Cancer. 2022;128:1359-1360.
    >> Share

    February 2022
  16. OSAKO T, Matsuura M, Yotsumoto D, Takayama S, et al
    A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study.
    Cancer. 2022 Feb 28. doi: 10.1002/cncr.34144.
    >> Share

  17. KISIEL JB, Papadopoulos N, Liu MC, Crosby D, et al
    Multicancer early detection test: Preclinical, translational, and clinical evidence-generation plan and provocative questions.
    Cancer. 2022;128 Suppl 4:861-874.
    >> Share

  18. CROWDER SL, Hoogland AI, Welniak TL, LaFranchise EA, et al
    Metagenomics and chemotherapy-induced nausea: A roadmap for future research.
    Cancer. 2022;128:461-470.
    >> Share

    January 2022
  19. ARUN BK, Peterson SK, Sweeney LE, Bluebond RD, et al
    Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
    Cancer. 2022;128:94-102.
    >> Share

    October 2021
  20. PINATTI LM, Gu W, Wang Y, Elhossiny A, et al
    SearcHPV: A novel approach to identify and assemble human papillomavirus-host genomic integration events in cancer.
    Cancer. 2021;127:3531-3540.
    >> Share

    August 2021
  21. HENDERSON V, Ganschow P, Wang C, Hoskins KF, et al
    Population screening to identify women at risk for hereditary breast cancer syndromes: The path forward or the road not taken?
    Cancer. 2021 Aug 23. doi: 10.1002/cncr.33867.
    >> Share

  22. NECCHI A, Cucchiara V, Grivas P, Bratslavsky G, et al
    Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer.
    Cancer. 2021 Aug 11. doi: 10.1002/cncr.33865.
    >> Share

  23. SCHRANK TP, Lenze N, Landess LP, Hoyle A, et al
    Genomic heterogeneity and copy number variant burden are associated with poor recurrence-free survival and 11q loss in human papillomavirus-positive squamous cell carcinoma of the oropharynx.
    Cancer. 2021;127:2788-2800.
    >> Share

    April 2021
  24. URICK ME, Yu EJ, Bell DW
    High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels.
    Cancer. 2021 Apr 19. doi: 10.1002/cncr.33567.
    >> Share

  25. CULVER JO, Ricker CN, Bonner J, Kidd J, et al
    Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
    Cancer. 2021;127:1275-1285.
    >> Share

  26. PARK S, Olsen S, Ku BM, Lee MS, et al
    High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean lung liquid versus invasive biopsy program.
    Cancer. 2021 Apr 7. doi: 10.1002/cncr.33571.
    >> Share

  27. PRINTZ C
    First person profile: Matthew L. Meyerson, MD, PhD: Pioneering scientist leads key discoveries in cancer genomics.
    Cancer. 2021;127:991-993.
    >> Share

  28. HENDERSON V, Chukwudozie IB, Comer-Hagans D, Coffey V, et al
    Development of a culturally sensitive narrative intervention to promote genetic counseling among African American women at risk for hereditary breast cancer.
    Cancer. 2021 Apr 1. doi: 10.1002/cncr.33525.
    >> Share

    October 2020
  29. YIN K, Singh P, Drohan B, Hughes KS, et al
    Breast imaging, breast surgery, and cancer genetics in the age of COVID-19.
    Cancer. 2020;126:4466-4472.
    >> Share

    June 2020
  30. IBRAHEEM A, Olopade OI, Huo D
    Propensity score analysis of the prognostic value of genomic assays for breast cancer in diverse populations using the National Cancer Data Base.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32956.
    >> Share

  31. DANCIU OC, Chen Z, Hoskins KF
    If you don't measure it, you can't improve it: Success and shortcomings of genomic assays in early breast cancer.
    Cancer. 2020 Jun 10. doi: 10.1002/cncr.32955.
    >> Share

    March 2020
  32. PASSARO A, Malapelle U, Attili I, de Marinis F, et al
    Overcoming resistance to osimertinib in non-small cell lung cancer: Hopes, doubts, and in-between.
    Cancer. 2020 Mar 10. doi: 10.1002/cncr.32810.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016